Rep. Porter Honored For Work on Budget

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 5
Volume 5
Issue 5

WASHINGTON--Representative John Edward Porter of Illinois has received an American Academy of Otolaryngology--Head and Neck Surgery, Inc. award for "superb legislative leadership for medical research."

WASHINGTON--Representative John Edward Porter of Illinois hasreceived an American Academy of Otolaryngology--Head and NeckSurgery, Inc. award for "superb legislative leadership formedical research."

Rep. Porter, in his first year as chairman of the House of Representative'sSubcommittee on Labor-HHS-Education and Other Related Agencies,succeeded in extricating medical research funding from the overallbudget battle, thus assuring continuation of medical researchat medical centers and universities throughout the country.

In presenting the award, Robert J. Ruben, MD, professor of pediatrics,Albert Einstein College of Medicine of the Yeshiva Universityand Montefiore Medical Center, New York City, said that Rep. Porter'sleadership "allows vital research work . . . to go forwarduninterrupted . . . not only in our field, but also in the fieldsof cancer, heart disease, and lung disease--indeed in all healthareas of profound interest to the American people, and peopleworldwide."

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.